Not applicableNot Yet RecruitingNCT05980208What this trial is testingA Real-world Study of Inetetamab for First-line Treatment of MBCWho this might be right forBreast CancerReal-world Study Hunan Cancer Hospital 150
Testing effectiveness (Phase 2)UnknownNCT05894486What this trial is testingPhase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Peking University 40
Testing effectiveness (Phase 2)Ended earlyNCT06478862What this trial is testingPromitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After TherapyWho this might be right forCancer of OvaryPancreatic Ductal Adenocarcinoma Lipomedix Pharmaceuticals Inc. 19
Large-scale testing (Phase 3)Study completedNCT00861094What this trial is testingRadiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerWho this might be right forEsophageal Cancer UNICANCER 266
Not applicableEnded earlyNCT03603652What this trial is testingNEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the LungWho this might be right forCancer of LungCancer of the LungLung Cancer+4 more Ethicon, Inc. 10
Large-scale testing (Phase 3)Study completedNCT03067792What this trial is testingFOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerWho this might be right forInoperable Gastric Cancer Yonsei University 52
Large-scale testing (Phase 3)Ended earlyNCT00925548What this trial is testingSTRIDE - STimulating Immune Response In aDvanced brEast CancerWho this might be right forBreast Cancer EMD Serono 16
Large-scale testing (Phase 3)Ended earlyNCT03773302What this trial is testingPhase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/TranslocationsWho this might be right forAdvanced CholangiocarcinomaFGFR2 Gene Mutation QED Therapeutics, a BridgeBio company 48
Not applicableUnknownNCT02119559What this trial is testingCirculating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell CarcinomaWho this might be right forMetastatic Head-and-neck Squamous-cell Carcinoma University Hospital, Montpellier 115
Testing effectiveness (Phase 2)Study completedNCT00872014What this trial is testingThe Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerWho this might be right forAdvanced Hepatocellular CarcinomaInoperable Hepatocellular Carcinoma Amgen 60
Testing effectiveness (Phase 2)Study completedNCT05355168What this trial is testingNeoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal CarcinomaWho this might be right forToxicity, Drug Anhui Provincial Hospital 35
Testing effectiveness (Phase 2)UnknownNCT03910712What this trial is testingPyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCWho this might be right forBreast Cancer FemaleHER2-positive Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast+3 more Peking Union Medical College Hospital 250
Testing effectiveness (Phase 2)Study completedNCT05918107What this trial is testingPM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPMWho this might be right forMPM Biotheus Inc. 31
Not applicableStudy completedNCT01777958What this trial is testingHELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin TherapyWho this might be right forBreast Cancer Hoffmann-La Roche 135
Testing effectiveness (Phase 2)Study completedNCT02131480What this trial is testingStudy of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic LeiomyosarcomaWho this might be right forUterus LeiomyosarcomaSoft Tissue Leiomyosarcoma Gustave Roussy, Cancer Campus, Grand Paris 110
Testing effectiveness (Phase 2)Looking for participantsNCT05344209What this trial is testingEfficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung CancerWho this might be right forOncologyNSCLC Stage IVNSCLC, Stage III Vestre Viken Hospital Trust 138
Testing effectiveness (Phase 2)Study completedNCT01743365What this trial is testingClinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric CancerWho this might be right forGastric CancerGastroesophageal Junction Cancer Hellenic Cooperative Oncology Group 55
Testing effectiveness (Phase 2)Study completedNCT01802632What this trial is testingAZD9291 First Time In Patients Ascending Dose StudyWho this might be right forAdvanced Non Small Cell Lung CancerAdvanced (Inoperable) Non Small Cell Lung Cancer AstraZeneca 603
Testing effectiveness (Phase 2)Ended earlyNCT02808247What this trial is testingPh II Nintedanib vs. Ifosfamide in Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)UnknownNCT03403101What this trial is testingThe Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic CancerWho this might be right forCarcinoma, Pancreatic Ductal Fudan University 65